Stakeholders concerned over Australian drug labelling and packaging proposals
This article was originally published in SRA
Executive Summary
Proposals by Australia's Therapeutic Goods Administration to improve the labelling and packaging of medicines are of concern to stakeholders who fear the recommendations might be too prescriptive, inflexible and costly1.